About us

Leukaemia Care is the UK’s leading leukaemia charity. For over 50 years, we have been dedicated to ensuring that everyone affected receives the best possible diagnosis, information, advice, treatment and support.

Who we are and what we do

Leukaemia Care is the UK’s leading leukaemia charity.

Our strategic plan

We exist to improve the lives of everyone affected by leukaemia, MDS and MPN. Over the last 50 years, we have come a long way, but there is more to be done.

Our Trustee Board

Here at Leukaemia Care we have a small but dedicated trustee board. Find out more about each member here…

Meet our Patrons and Ambassadors

Our Patrons help to raise awareness of our charity, blood cancers and issues facing patients and their families. We are grateful to them all for their wonderful support.

Vacancies

Find out more about the latest vacancies at Leukaemia Care.

Volunteering opportunities

Contribute your time and expertise to enhance the lives of those impacted by leukaemia through volunteering with us.

Privacy policy

The Leukaemia Care privacy policy as of 6th March 2024

Contact us

For all general enquiries, information about events, fundraising or anything else, including requests for resources get in touch with us today using any of the details below.

Press and media centre

Looking to write an article about Leukaemia? We've got some of the facts and statistics that you can quote.

Annual accounts and reports

View our annual report and financial statements for the year ended in December 2021.

Fundraising promise

Supporters drive everything we do at Leukaemia Care. It’s thanks to your generosity that we are able to support so many leukaemia patients, read on to learn more about our fundraising promise.

Our complaints procedure

Read more about our complaints procedure below.

Vacancies

Find out more about the latest vacancies at Leukaemia Care.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

April 23rd

Cost of leukaemia – Tony Pullen on sick pay

Tony Pullen talks openly about how being diagnosed with hairy cell leukaemia (HCL) has impacted his financial stability. ...

April 11th

Approval for the first CAR-T treatment for ALL is renewed

CAR-T therapy, tisagenlecleucel, has been given long term approval to be used on the NHS in England, thanks to a decision made by the National Institute for Health and Care Excellence's (NICE). ...

March 11th

NEW oral treatment for AML patients approved in Scotland

Leukaemia Care are pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patient with an IDH1 mutation who are ineligible for standard induction chemotherapy now have access to ivosidenib with azacitidine thanks to the decision made by the Scottish Medicines Consortium (SMC) today....